Fibromyalgia Treatment with Chiropractic

If you are afflicted by fibromyalgia, you are not alone, as Dr. James Ellis & Dr. Lyndsay Martin sees many patients with this particular condition in our Woburn & Chelmsford, MA chiropractic clinic. In fact, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the US have fibromyalgia. Thankfully, chiropractic is one treatment option that can provide positive results.

Research Shows Chiropractic Helps Fibromyalgia

In a medical study released in mid-2015, 215 women and men with fibromyalgia were evaluated based on factors ranging from pain to quality of sleep to the levels of depression or anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal therapy plan for three months and the second group receiving the same program plus chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The individuals who received chiropractic adjustments combined with the multi-disciplinary treatment approach reported greater benefits in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study participants who received multi-modal treatment without chiropractic. Furthermore, those positive benefits were lasting as the subjects reported continued improvement one full year later.

Fibromyalgia can substantially decrease your quality of life, both mentally and physically. If you're struggling with fibromyalgia, we might be able to help.

You don't have to suffer! To see what Dr. James Ellis & Dr. Lyndsay Martin can do for your fibromyalgia pain, call our Woburn & Chelmsford, MA chiropractic office today.

References

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.